Frontiers in Cardiovascular Medicine

JANUARY 20, 2025

BackgroundPatients who underwent surgical repair of supravalvular aortic stenosis (SVAS) are at high risk for postoperative major adverse cardiovascular events (MACE).

Stenosis 52

Stenosis Aortic Hospital Research 52

JAMA Cardiology

FEBRUARY 11, 2025

This Viewpoint advocates for prompt aortic valve replacement (rather than clinical surveillance) as the default strategy for patients with asymptomatic severe aortic stenosis.

Aortic valve 93

Aortic valve Aortic Stenosis 93

DAIC

JANUARY 11, 2024

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT. Curved multiplanar reformatted images at varying virtual monoenergetic imaging (VMI) levels (40-140 keV) show stenosis at each level. Percent diameter stenosis (PDS) decreased from 92.5% at 40 keV to 53.1% at 140 keV. at 140 keV.

Stenosis 105

Stenosis Plaque 105

DAIC

MARCH 25, 2024

The global, randomized trial ( envisiontrial.com ) will evaluate the safety and effectiveness of Abbott’s minimally invasive Navitor transcatheter aortic valve implantation (TAVI) system in approximately 1,500 patients at intermediate or low surgical risk with severe aortic stenosis (narrowing of the aortic valve). fall into this category.

Stenosis 115

Stenosis Aortic Aortic valve Heart Valves 115

Heart BMJ

FEBRUARY 26, 2025

The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. Background Health inequalities in cardiovascular care have been identified in the UK.

Aortic valve 52

Aortic valve Aortic COVID-19 Stenosis 52

JAMA Cardiology

OCTOBER 15, 2024

This narrative review analyzes associations among heart failure, aortic stenosis, and aortic valve replacement.

Aortic valve 89

Aortic valve Heart Failure Aortic Stenosis 89

Cardiovascular Diabetology

MARCH 13, 2024

The association of the triglyceride-glucose (TyG) index with intracranial atherosclerotic stenosis (ICAS) and extracranial atherosclerotic stenosis (ECAS) is unclear. This study aimed to investigate the relati.

Stenosis 105

Stenosis Research 105

Frontiers in Cardiovascular Medicine

MARCH 12, 2025

IntroductionPercutaneous balloon valvuloplasty is the treatment of choice for critical pulmonary valve stenosis (CPS) and pulmonary valve atresia with intact ventricular septum (PA/IVS) if the ventricle has a suitable size. The Z-scores of pulmonary valve diameter, balloon/annulus ratio, number of cusps, and persisting stenosis were analyzed.

Pulmonary 52

Pulmonary Stenosis Outcomes Hospital 52

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV).

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

American College of Cardiology

MAY 6, 2025

FAVOR III Europe (Functional Diagnostic Accuracy of Quantitative Flow Ratio in Online Assessment of Coronary Stenosis III Europe) was a multicenter, randomized, open-label, noninferiority trial to compare clinical outcomes of quantitative flow ratio (QFR)-guided and fractional flow reserve (FFR)-guided revascularization in patients with intermediate (..)

Stenosis 67

Stenosis Outcomes Article 67

DAIC

MARCH 31, 2025

These patients had a predicted 30-day mortality risk "Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," saidMichael J. Reardon, M.D.,

TAVR 52

TAVR Stenosis Aortic Outcomes 52

JAMA Cardiology

JULY 16, 2024

This meta-analysis evaluates lipoprotein(a) concentrations and hemodynamic progression in patients with aortic stenosis.

Stenosis 76

Stenosis Aortic valve Aortic 76

Heart BMJ

APRIL 10, 2025

Since the first implementation in 2002 by Alain Cribier, transcatheter aortic valve replacement (TAVR) has become a standard procedure for high-risk and elderly patients with severe aortic valve stenosis. Recently, the use of TAVR has expanded to relatively younger patients with low to moderate surgical risk.

Aortic valve 102

Aortic valve Aortic TAVR Stenosis 102

JAMA Cardiology

APRIL 5, 2024

This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.

Stenosis 85

Stenosis Biomarkers Aortic 85

American College of Cardiology

MAY 24, 2024

What is the relationship between aortic valve calcification (AVC) and aortic stenosis (AS) severity in patients with suspected low-flow low-gradient AS?

Aortic valve 72

Aortic valve Aortic Stenosis Article 72

Science Daily - Heart Disease

MAY 8, 2025

Aortic stenosis is a progressive and potentially fatal condition, affecting about five per cent of 65-year-olds in the US -- with increasing prevalence in advancing age. The new study reveals how a four-dimensional flow (4D flow) MRI scan can diagnose aortic stenosis more reliably than current ultrasound techniques.

Stenosis 62

Stenosis Aortic Chest Pain Ultrasound 62

Medical Xpress - Cardiology

OCTOBER 29, 2024

Until now, patients with aortic stenosis—a narrowing of one of the heart's main valves—have had to wait until symptoms become severe before undergoing valve replacement.

Stenosis 81

Stenosis Aortic Chest Pain 81

Journal of the American Heart Association

MARCH 13, 2025

BackgroundOur previous preclinical study demonstrated thatAPOE4targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment thanAPOE3targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction.

Stenosis 75

Stenosis Risk Factors Circulation 75

American College of Cardiology

MARCH 29, 2025

25 in Chicago and simultaneously published in the NEJM.

Heart Failure 75

Heart Failure Stenosis Aortic Article 75

Circulation: Cardiovascular Imaging

MAY 5, 2025

Circulation: Cardiovascular Imaging, Ahead of Print.

Bicuspid/Mitral 40

Bicuspid/Mitral Stenosis Cardiovascular Imaging Aortic 40

American College of Cardiology

FEBRUARY 21, 2024

Echocardiography remains the principal imaging modality for detection and diagnosis of aortic stenosis (AS), as well as for grading of severity.

Stenosis 75

Stenosis Aortic Article 75

Journal of the American Heart Association

DECEMBER 20, 2023

BackgroundThe utility of screening for the degree of common carotid artery (CCA) stenosis as a predictor of cardiovascular disease (CVD) in a general population remains unclear.Methods and ResultsWe studied 4775 Japanese men and women whose CCA was measured using bilateral carotid ultrasonography at baseline (April 1994–August 2001).

Stenosis 78

Stenosis Cardiovascular Disease Plaque Heart Disease 78

American College of Cardiology

SEPTEMBER 27, 2024

How does diffuse interstitial myocardial fibrosis, as observed on cardiac magnetic resonance (CMR), correlate with clinical outcomes in moderate and asymptomatic severe aortic stenosis (AS)?

Stenosis 60

Stenosis Aortic Outcomes Article 60

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundAortic valve calcium score is associated with hemodynamic severity of aortic stenosis. There was no correlation between MAC calcium score and mitral valve area (r=0.07;P=0.6) or mitral valve gradient (r=−0.03;P=0.8).ConclusionsMAC

Bicuspid/Mitral 74

Bicuspid/Mitral Stenosis Atrial Fibrillation Coronary Artery Disease 74

American College of Cardiology

OCTOBER 28, 2024

The goal of the EARLY TAVR trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with clinical surveillance among patients with asymptomatic severe aortic stenosis (stage C aortic stenosis).

TAVR 63

TAVR Stenosis Aortic Aortic valve 63

Med Page Today

OCTOBER 28, 2024

(MedPage Today) -- Transcatheter aortic valve replacement (TAVR) yielded clinical benefit when given early in the disease process while patients still had no symptoms or other indication for aortic valve replacement, according to the EARLY TAVR.

TAVR 105

TAVR Aortic Aortic valve Stenosis 105

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

This study aimed to investigate the predictive value of RC and lipid ratios alone or in combination for the severity of coronary artery stenosis in patients with coronary heart disease (CHD).MethodsThe CHD patients were categorized into mild stenosis and moderate-to-severe stenosis groups.

Cholesterol 52

Cholesterol Heart Disease Stenosis Risk Factors 52

American College of Cardiology

SEPTEMBER 18, 2024

The goal of the AVATAR trial was to evaluate aortic valve replacement (AVR) compared with conservative therapy among patients with asymptomatic severe aortic stenosis.

Aortic valve 64

Aortic valve Aortic Stenosis Article 64

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

This concept should be applied when managing older patients with severe aortic stenosis. Although left ventricular wall hypertrophy is expected in patients with aortic stenosis, it should not be assumed that this is caused only by aortic stenosis.

Stenosis 69

Stenosis Aortic TAVR Aortic valve 69

Med Page Today

MAY 3, 2025

(MedPage Today) -- WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 years for people with carotid artery stenosis deemed poor candidates for surgery, based on the PERFORMANCE.

Stents 56

Stents Stent Embolism Stenosis 56

Med Page Today

JANUARY 16, 2025

(MedPage Today) -- People with transthyretin cardiac amyloidosis (ATTR-CA) on top of aortic stenosis (AS) fared particularly poorly in a large cohort study, which researchers said calls for awareness and timely treatment. Compared with AS alone.

Stenosis 59

Stenosis Aortic Outcomes Research 59

American College of Cardiology

MARCH 30, 2025

25 in Chicago and simultaneously published in the The Lancet.

Stenosis 64

Stenosis Research Outcomes Article 64

American College of Cardiology

NOVEMBER 20, 2024

Which genetic and cardiovascular risk factors are aortic stenosis (AS)-specific, and which could be shared between AS and with coronary artery disease (CAD)?

Stenosis 53

Stenosis Aortic Coronary Artery Disease Risk Factors 53

American College of Cardiology

FEBRUARY 26, 2025

In this weeks View, Dr. Eagle looks at the potential exposure-dependent protective effect of SGLT2 inhibitors on aortic valve stenosis progression.

Aortic valve 63

Aortic valve Stenosis Aortic AFIB 63

Circulation

NOVEMBER 11, 2024

However, the most recurrent cardiac complication in RASopathies is pulmonary valve stenosis (PVS). This has motivated compassionate use of MEK inhibition (MEKi) for rare, but potentially lethal complications such as hypertrophic cardiomyopathy and lymphatic disease.

Stenosis 75

Stenosis Pulmonary Cardiomyopathy Circulation 75

Cassling

JANUARY 9, 2025

EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aortic stenosis. With its unparalleled access to extensive echocardiographic data and AI-driven analysis, EchoSolv empowers clinicians to identify aortic stenosis earlier and with greater accuracy.

Heart Disease 52

Heart Disease Stenosis Aortic Innovation 52

Cardiovascular Diabetology

MAY 12, 2025

Patients diagnosed with both aortic stenosis (AS) and diabetes mellitus (DM) encounter a distinctive set of challenges due to the interplay between these two conditions. This study aimed to investigate the eff.

Stenosis 52

Stenosis Aortic Diabetes Research 52